ENTERO VU 24%

Peak

barium sulfate

NDAORALSUSPENSION

Approved

Jan 2016

Lifecycle

Peak

Competitive Pressure

30/100

Mechanism of Action

X-Ray Contrast Activity

Pharmacologic Class:

Radiographic Contrast Agent

Company

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers